Abstract Details
| Daphne Robakis, MD (Sanofi) | Dr. Robakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal pharmaceuticals. |
| Anna Marisa Cervantes-Arslanian, MD, FAAN (BU Dept of Neurology) | Dr. Cervantes-Arslanian has nothing to disclose. |
| Aleksandra Pikula, MD | The institution of Dr. Pikula has received research support from CIHR. |
| No disclosure on file |